← Back to guidelines
Cardiology9 papers

Microangiopathic hemolytic anemia

Last edited: 4/15/2026

Overview

Microangiopathic hemolytic anemia (MAHA) is characterized by the presence of schistocytes (fragmented red blood cells) on peripheral blood smear, indicative of microvascular damage leading to hemolysis and thrombosis 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of schistocytes on peripheral blood smear, often with other morphological changes in red blood cells 1.
  • Recommended Tests: Peripheral blood smear analysis following International Council for Standardization in Hematology (ICSH) recommendations for schistocyte determination 1.
  • Grading: Schistocyte percentage can help differentiate between various underlying conditions; higher percentages (>1%) often correlate with more severe disease states 1.
  • Management

  • First-Line Treatments: Specific treatments depend on underlying etiology; for example, plasma exchange in suspected thrombotic thrombocytopenic purpura (TTP) 1.
  • Adjunctive Treatments: Supportive care including blood transfusions, management of underlying conditions (e.g., sepsis, malignancy), and monitoring for complications 1.
  • Special Populations

  • Pediatrics: Schistocytes are observed in preterm infants, indicating MAHA can occur in this population 1.
  • Comorbidities: Patients with chronic renal failure, sepsis, and metastatic carcinoma frequently exhibit schistocytes, suggesting careful evaluation of these comorbidities in MAHA diagnosis 1.
  • Key Recommendations

  • Utilize ICSH guidelines for accurate schistocyte determination in diagnosing MAHA across various clinical contexts (Evidence: Moderate) 1.
  • Consider underlying etiologies beyond TTP/HUS, as schistocytes are commonly observed in conditions like sepsis and chronic renal failure (Evidence: Moderate) 1.
  • Tailor management strategies based on identified underlying causes, with specific interventions like plasma exchange reserved for confirmed TTP (Evidence: Expert opinion) 1.
  • References

    1 Huh HJ, Chung JW, Chae SL. Microscopic schistocyte determination according to International Council for Standardization in Hematology recommendations in various diseases. International journal of laboratory hematology 2013. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG